Prediabetes in 2026: Evidence Thresholds for Lifestyle Intervention, Metformin, and Anti-Obesity Pharmacotherapy

Prediabetes in 2026: Evidence Thresholds for Lifestyle Intervention, Metformin, and Anti-Obesity Pharmacotherapy Review Abstract Purpose This review examines when lifestyle intervention, metformin, and anti-obesity pharmacotherapy are most appropriate for adults with prediabetes. The objective is to clarify the role of each strategy using current clinical

Latest Research Exploring Metformin Connection To Breast Cancer

Latest Research Exploring Metformin Connection To Breast Cancer Overview This study aimed to investigate the relationship between metformin and other antidiabetic medications and the incidence of breast cancer in two large prospective cohort studies. It included 185,181 women from the Nurses' Health Study (NHS; 1994–2016) and NHSII (1995–2017). Information on type 2

Prediabetes in 2026: Evidence Thresholds for Lifestyle Intervention, Metformin, and Anti-Obesity Pharmacotherapy